Staff in the School of Cancer Sciences

 

Professor Alan Bernard Rickinson

Professor Alan Bernard Rickinson

Professor of Cancer Studies

Alan Rickinson led the development of the Institute of Cancer Studies (now School of Cancer Sciences) at the University of Birmingham from 1983 to 2001, overseeing its expansion from a small non-clinical research department into a large research institute integrating basic work on cancer genetics, viral oncology and tumour immunology with translational studies in gene/ immunotherapy and ...

Dr Sally Roberts

Dr Sally Roberts

Senior Lecturer

Sally qualified with a B.Sc. (Hons) in Biochemistry from the University of Warwick in 1981. She gained a D.Phil. from the Laboratory of Molecular Biophysics in the University of Oxford in 1987 and was then appointed as a Research Fellow in the Department of Cancer Studies in the University of Birmingham. In 1999, she was appointed Lecturer in Cancer Studies and in 2002 promoted to Senior ...

Professor Martin Rowe

Professor Martin Rowe

Professor of Tumour Virology

Martin Rowe is Professor of Tumour Virology and heads the Viral Oncology Research Theme within the College of Medical and Dental Sciences.

Martin has published more than 160 research papers in scientific journals as well as reviews and book chapters in the fields of virology, cancer and tumour immunology. He has received major grants from Cancer Research UK, Leukaemia Lymphoma ...

Dr Peter Searle

Senior Lecturer

Peter Searle is a Senior Lecturer in the School of Cancer Sciences.

He has published over 70 research papers in scientific journals, and received grant funding from the Medical Research Council and Cancer Research UK.

He is keen to apply the advances from basic research to the development of novel therapies for cancer, and his research now has a focus on developing ...

Dr Claire Shannon-Lowe

Dr Claire Shannon-Lowe

MRC Research Fellow

Claire Shannon-Lowe is an MRC funded Research Fellow at the School of Cancer Sciences.

Claire has published research papers in scientific journals on the mechanism of Epstein Barr virus (EBV) entry into cell types lacking the virus receptor, including epithelial cells, T cells and NK cells. EBV infection of these cell types is strongly associated with various ...

Professor Tatjana Stankovic

Professor Tatjana Stankovic

Professor in Cancer Genetics

Tatjana Stankovic is a Professor in Cancer Genetics.

Tatjana Stankovic has published over 60 research papers in high impact scientific journals as well as reviews in the fields of cancer genetics and DNA damage response. She has received grants from the Leukaemia Research Fund, Cancer Research UK , Kay Kendall Leukaemia Fund, and CLIC.

She is an ...

Dr Neil M Steven

Deputy Clinical Director, CRUK Clinical Trials Unit.
Deputy Clinical Director, CRUK Clinical Trials Unit
Honorary Consultant in Medical Oncology, University Hospital Birmingham NHS Foundation Trust

Dr Neil Steven is a consultant treating people with cancer.  He uses chemotherapy to treat people with colorectal carcinoma: to prevent recurrence after they have had surgery or to treat advanced metastatic disease.  He uses systemic therapy for people with advanced aggressive skin cancers, mostly melanoma or Merkel cell carcinoma.  In both settings, he works as part of a ...

Dr Grant Stewart

Dr Grant Stewart

Reader in Cancer Genetics

Dr Grant Stewart is a CR-UK Career Development and Lister Institute Fellow, who runs a laboratory within the College of Medicine and Dentistry, School for Cancer Sciences.

The principle focus of the research ongoing within Dr. Stewart’s laboratory is understanding how the cellular recognises and responds to genetic damage, such as DNA breaks and DNA inter-strand cross-links, ...

Mrs Sudha Sundar

Mrs Sudha Sundar

Senior Lecturer in Gynaecological Oncology

Dr Sundar is a Senior Lecturer in Gynaecological Oncology and a Consultant in Gynaecological Oncology at the Pan Birmingham Gynaecological Cancer Centre, City Hospital. 

 

 

Dr Graham Taylor

Lecturer in Tumour Immunology

Graham Taylor joined the School of Cancer Sciences in 2000 with a background in virology and has since developed a research portfolio studying the immune response to Epstein Barr Virus, a common human pathogen that is associated with a number of different types of cancer. 

Part of this work has been to help develop a vaccine to treat patients with such cancers. The ...